Chemotherapy of experimental meningeal carcinomatosis.
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D007276:Injections, Intraventricular; D008130:Lomustine / Q000008:administration & dosage / Q000627:therapeutic use; D008578:Meninges; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D012673:Semustine / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D012673:Semustine; D008130:Lomustine; D003520:Cyclophosphamide; D008727:Methotrexate